This is the national team's responsible author| Yan Xiaoliu Shenzhen is the first city in China to launch a local head-on confrontation with the new crown virus mutation strain. In this year's "5.21" and "6.14" epidemics...
hospital antibody Covid Shenzhen Third Hospital brii Coronavirus
12-18
On the evening of December 12, Tengsheng Bo Pharmaceutical announced that new in vitro chimeric virus experiments neutralized data indicate that its combination therapy of ampavirus monoclonal antibody/romizumab (previously known as BRII-19...
Tengsheng Bo medicine omicron brii Tengsheng Huachuang Novel coronavirus
12-12